World Cancer Day 2026 takes place on 4 February and continues the global theme “United by Unique” (2025–2027), highlighting the importance of people-centred cancer care and recognising that every cancer journey is different.
Genomic medicine plays a vital role in delivering earlier, more personalised and equitable cancer diagnosis and treatment across the NHS. By understanding the genetic changes that drive cancer, clinicians can better tailor care to each patient’s needs.
Mainstreaming genomics into routine cancer pathways supports:
-
Earlier diagnosis and risk assessment
-
Precision medicine through tumour profiling
-
Identification of targetable treatment options
-
Monitoring of treatment response using circulating tumour DNA (ctDNA)
Across the North West, work continues to embed genomic testing into everyday cancer care, reduce variation and improve access for all patients. This includes successful mainstreaming programmes such as routine testing for inherited cancer conditions like Lynch syndrome, helping to save lives through earlier detection and prevention.
To read our mainstreaming and equity strategy, please visit: Spotlight: Mainstreaming and equity